News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
Moderna Inc. shares declined after the company’s first-quarter vaccine sales missed estimates and it disclosed a delay in the ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
The FDA has rehired at least some workers tasked with releasing public records generated by the agency’s regulatory ...
20h
Scripps News on MSNHHS, NIH announce development of universal vaccine for COVID-19 and influenzaResearchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...
The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results